Validation of an HIV-1 inactivation protocol that is compatible with intracellular drug analysis by mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 15;847(1):38-44. doi: 10.1016/j.jchromb.2006.10.001. Epub 2006 Oct 20.

Abstract

Mass spectrometry is a powerful tool for studying the intracellular pharmacokinetics of antiretroviral drugs. However, the biohazard of HIV-1 calls for a safety protocol for such analyses. To this end, we extracted HIV-1 producing cells with methanol or ethanol at 4 degrees C. After extraction, no viral infectivity was detected, as shown by a reduction in infectious titers of more than 6log. In addition, this protocol is compatible with the quantitative analysis of antiretroviral drugs in cell extracts using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS. Thus, using this protocol, infectious HIV-1 is inactivated and antiretroviral drugs are extracted from cells in a single step.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Anti-HIV Agents / analysis*
  • Anti-HIV Agents / pharmacology
  • Cell Extracts / chemistry
  • Cells, Cultured / virology
  • Ethanol / chemistry
  • HIV-1 / drug effects*
  • HIV-1 / isolation & purification
  • Humans
  • Methanol / chemistry
  • Ritonavir / analysis*
  • Ritonavir / pharmacology
  • Sensitivity and Specificity
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / methods*
  • Virus Inactivation*

Substances

  • Anti-HIV Agents
  • Cell Extracts
  • Ethanol
  • Ritonavir
  • Methanol